William Bobo, M.D.
Assistant Professor of Psychiatry
William.V.Bobo@Vanderbilt.edu
Dr. Bobo has been a member of the faculty since July 2006. He graduated from the University of Missouri-Columbia School of Medicine in 1998, and completed residency training in general psychiatry at the National Capital Consortium (NCC) Military Psychiatry Residency Program located at the National Naval Medical Center (Bethesda, MD) and Walter Reed Army Medical Center (Washington, DC) in 2002. After serving as the director of the inpatient psychiatry and consultation-liaison services at Naval Hospital, Jacksonville (FL) from 2002-2004, Dr. Bobo became the Deputy Director of the NCC residency program until July 2006. Currently, Dr. Bobo divides his time between clinical and pharmacoepidemiological research focused on long-term effects of antipsychotic drug treatment, as well as patient care duties and resident education.
Education
M.D., University of Missouri-Columbia School of Medicine (Columbia, MO)
BS, Northwest Missouri State University (Maryville, MO)
Postgraduate Training
Resident in Adult Psychiatry, Military Psychiatry Residency Training Program
Areas of Clinical Expertise
Schizophrenia and related psychotic disorders
Research interests
Psychopharmacological treatment of schizophrenia and related disorders
Representative Publications
1. Bobo WV, Stovall J, Knostman M, Koestner J, Shelton RC. Converting from brand-name to generic clozapine: a review of effectiveness and tolerability data. American Journal of Health-System Pharmacy 2009; in press.
2. Bobo WV, Jayathilake K, Lee MA, Meltzer HY. Changes in weight and body mass index during treatment with melperone, clozapine and typical neuroleptics. Psychiatry Research 2009; in press.
3. Meltzer HY, Bobo WV. Chapter 6.2.5 Antipsychotic and anticholinergic drugs. In: MG Gelder, J Jose Lopez-Ibor & NC Andreasen. New Oxford Textbook of Psychiatry. Oxford, UK: Oxford University Press, in press.
4. Bobo WV, Meltzer HY. Duration of untreated psychosis and premorbid functioning: relationship with treatment response and therapy-resistant schizophrenia. In: H Elkis & HY Meltzer. Advances in Biological Psychiatry Therapy-Resistant Schizophrenia. Basel, Switzerland: S Karger, AG, in press.
5. Bobo WV, Murphy MJ, Heckers SH. Recurring episodes of delirious mania after cerebrovascular accident with full response to oral lorazepam: a single case report. Psychosomatics 2009; in press.
